Shares of Cresco Labs (CSE:CL)(OTCQX:CRLBF) are on the rise 6.07% to press time and selling for $10.49 USD. The company announced that it received regulatory approval for its acquisition “of 100% of the membership interests of Gloucester Street Capital, LLC, the parent entity of Valley Agriceuticals, LLC via a merger between Gloucester and an indirect subsidiary of Cresco Labs”.
The news has caused shares to surge—a much-needed respite for this ailing stock that has lost over 33% since mid-June.Cresco Labs – Damaged In Recent Months
Cresco is one of the US’s largest, multi-state, ...
Get the latest marijuana stock news, cannabis on stock news on PotStockNews